Logo
Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents
July 19, 2017

Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis

Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents

Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents


The Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis which was published in the International journal of antimicrobial agents. Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasis - International Journal of Antimicrobial Agents Human African trypanosomiasis (HAT) is a neglected tropical disease, with a population of 70 million at risk. Current treatment options are limited.


In the search for new therapeutics, the repurposing of the broad-spectrum antiprotozoal drug fexinidazole has completed Phase III trials with the anticipation that it will be the first oral treatment for HAT.


For more information please see - https://www.sciencedirect.com/journal/international-journal-of-antimicrobial-agents

February 18, 2025
We’re thrilled to offer Haematology Services to advance drug development and research. Our lab features, the Siemens analyser, delivering precise results across key biological parameters. 🔬 Services Include: Full Blood Count (FBC) Reticulocytes Differential Analysis 🐾 Supporting human and animal models 💡 Applications: Diagnose blood disorders (anaemia, leukaemia and others). Evaluate treatment efficacy in preclinical models. Translate findings from animals to humans. 📦 Sample Details: Minimum 200 µL of EDTA whole blood. Reach out today to learn how we can support your research!
February 13, 2025
We had great fun networking, supporting wellbeing, nurturing our community and raising money for Stevenage based STEMPOINT , the educational charity dedicated to widening access into science, engineering, maths and technology subjects across EastAnglia. Over 30 players took part in the cross-campus sports event, we welcomed teams from GSK, ImmuONE, Tessellate BIO, Neobe Therapeutics, Stevenage Bioscience Catalyst, Pharmidex , MFX, Antikor Biopharma Ltd – and of course STEMPOINT - who came to join us. Congratulations goes to Ash Alavijeh from Pharmidex who won best player of the rally! See you all again in the next badminton tournament in the Spring!
OBN Science Social
February 12, 2025
Pharmidex at OBN Science Social
More Posts
Share by: